Our Commitment Is:

Wide Range High-Quality
Reasonably Priced Medications

Field of Activities and Global Responsibilities

Our Diverse Portfolio: Beyond Oncology to Holistic Treatment Approaches

While our primary focus remains on pioneering cancer therapies, NanoAlvand also excels in developing advanced treatments for multiple sclerosis, rheumatoid arthritis, immunosuppressants medications, and other innovative medicines.

+12
Exporting Destinations
3
Export Continents
+20
Registration Projects
+126
Total FDF

Partnering

Finding the ideal partner and developing a preliminary business case based on the country’s needs are the first steps in our partnership process. The process will proceed from initial negotiations to the signing and finalization of agreements, incorporating a thorough due diligence phase before making a strategic entry into the target market. Serving our clients' needs by providing access to wide range of high-quality, reasonably priced medications is the mission of our business development team.


Business Models

Supply and Distribution


Product Development


Joint-Venture

Technology Transfer


Contract Manufacturing


In-licensing

NanoAlvand Products

Injectables Formulations
Solution Vial
Lyophilized Vial
Pre-Filled Syringe
Oral Formulations
Tablet
Micro-Tablet
Capsule

Our Partners

Unlock Opportunities. Become a partner with NanoAvand and join forces with a leader in healthcare innovation.

Collaborate with us to drive advancements, expand market reach, and create impactful solutions. Let's shape the future together-explore partnership possibilities today.


© NanoAlvand. All rights reserved. Powered by ِDGN.